FO supplementation did not modify the PARP-1 protein expression in tumor tissue (W 1.03 ± 0.02 vs. WFO 1.08 ± 0.03 vs. WCO 1.04 ± 0.05) (Fig. 6). This evidence concerns the gene PARP1 and neoplasm.